Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4120)
All Articles published online
|
Jan 14, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu WC, Zhao W, Li S. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World J Gastroenterol 2008; 14(2): 313-317 [PMID: 18186574 DOI: 10.3748/wjg.14.313] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i2/313.htm |
| Number | Citing Articles |
| 1 |
Kouichi Miura, Yuzo Kodama, Sayaka Inokuchi, Bernd Schnabl, Tomonori Aoyama, Hirohide Ohnishi, Jerrold M. Olefsky, David A. Brenner, Ekihiro Seki. Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice. Gastroenterology 2010; 139(1): 323 doi: 10.1053/j.gastro.2010.03.052
|
| 2 |
Jian Zhang, Chunying Wang, Ji Wang, Fengchi Zhang. Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5490
|
| 3 |
Yizhe Cui, Qiuju Wang, Renxu Chang, Xiaocui Zhou, Chuang Xu. Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. Journal of Agricultural and Food Chemistry 2019; 67(10): 2754 doi: 10.1021/acs.jafc.9b00080
|
| 4 |
Natalya V. Bakulina, Sergey V. Tikhonov, Elena I. Ermolenko, Marina P. Kotyleva, Nadezhda S. Lavrenova, Yulia G. Topalova, Vladimir I. Simanenkov, Alexander N. Suvorov. The use of <i>E. faecium</i> probiotic and autoprobiotic in patients with type 2 diabetes mellitus. HERALD of North-Western State Medical University named after I.I. Mechnikov 2022; 14(1): 77 doi: 10.17816/mechnikov104795
|
| 5 |
Phillipp Hartmann, Bernd Schnabl. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease 2021; 41(01): 087 doi: 10.1055/s-0040-1719174
|
| 6 |
Chaoyue Ma, Dan Liu, Huifang Hao, Xiaotong Wu. Identification of the DPP-IV Inhibitory Peptides from Donkey Blood and Regulatory Effect on the Gut Microbiota of Type 2 Diabetic Mice. Foods 2022; 11(14): 2148 doi: 10.3390/foods11142148
|
| 7 |
E. Ermolenko, S. Sitkin, T. Vakhitov, O. Solovyeva, A. Karaseva, A. Morozova, M. Kotyleva, I. Shumikhina, N. Lavrenova, E. Demyanova, A. Dmitriev, A. Suvorov. Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome. Beneficial Microbes 2023; 14(2): 119 doi: 10.3920/BM2022.0053
|
| 8 |
Shunyi Li, Kyosuke Yakabe, Khadijah Zai, Yiwei Liu, Akihiro Kishimura, Koji Hase, Yun-Gi Kim, Takeshi Mori, Yoshiki Katayama. Specific adsorption of a β-lactam antibiotic in vivo by an anion-exchange resin for protection of the intestinal microbiota. Biomaterials Science 2021; 9(21): 7219 doi: 10.1039/D1BM00958C
|
| 9 |
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Ryota Masuzaki, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(4): 1525 doi: 10.3390/ijms21041525
|
| 10 |
Silvia Ferolla, Geyza Armiliato, Cláudia Couto, Teresa Ferrari. The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease. Nutrients 2014; 6(12): 5583 doi: 10.3390/nu6125583
|
| 11 |
Ruiting Han, Junli Ma, Houkai Li. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Frontiers of Medicine 2018; 12(6): 645 doi: 10.1007/s11684-018-0645-9
|
| 12 |
Ivan Viegas, Giada Di Nunzio, Getachew D. Belew, Alejandra N. Torres, João G. Silva, Luis Perpétuo, Cristina Barosa, Ludgero C. Tavares, John G. Jones. Integration of Liver Glycogen and Triglyceride NMR Isotopomer Analyses Provides a Comprehensive Coverage of Hepatic Glucose and Fructose Metabolism. Metabolites 2022; 12(11): 1142 doi: 10.3390/metabo12111142
|
| 13 |
Naoko Ohtani, Tomonori Kamiya, Norifumi Kawada. Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond. Hepatology Communications 2023; 7(9) doi: 10.1097/HC9.0000000000000241
|
| 14 |
Fouad M. F. Elshaghabee, Namita Rokana, Harsh Panwar, Knut J. Heller, Jürgen Schrezenmeir. Probiotics for dietary management of non-alcoholic fatty liver disease. Environmental Chemistry Letters 2019; 17(4): 1553 doi: 10.1007/s10311-019-00896-8
|
| 15 |
Antonio Tursi, Walter Elisei, Gian Marco Giorgetti, Giovanni Brandimarte, Fabio Aiello. Complications in Celiac Disease Under Gluten-Free Diet. Digestive Diseases and Sciences 2009; 54(10): 2175 doi: 10.1007/s10620-008-0595-1
|
| 16 |
Seong-Eun Kim. Small Intestinal Bacterial Overgrowth. Intestinal Research 2010; 8(2): 106 doi: 10.5217/ir.2010.8.2.106
|
| 17 |
Ahmed Abu Shanab, Paul Scully, Orla Crosbie, Martin Buckley, Liam O’Mahony, Fergus Shanahan, Sanaa Gazareen, Eileen Murphy, Eamonn M. M. Quigley. Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8. Digestive Diseases and Sciences 2011; 56(5): 1524 doi: 10.1007/s10620-010-1447-3
|
| 18 |
Han Li, Yin-Ping Wang. Effect of Auricular Acupuncture on Gastrointestinal Motility and Its Relationship with Vagal Activity. Acupuncture in Medicine 2013; 31(1): 57 doi: 10.1136/acupmed-2012-010173
|
| 19 |
Ki Tae Suk, Dong Joon Kim. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(3): 193 doi: 10.1080/17474124.2019.1569513
|
| 20 |
Shan Jiang, Xiaolu Wei, Hongjie Wang, Yanyan Zhou, Lihua Chen, Lianmei Wang, Feng Wang, Qilong Wu, Nan Si, Baolin Bian, Haiyu Zhao. Biotransformed bear bile powder alleviates diet-induced nonalcoholic fatty liver disease in mice by regulating the gut microbiota and reversing lipid metabolism. Arabian Journal of Chemistry 2024; 17(2): 105578 doi: 10.1016/j.arabjc.2023.105578
|
| 21 |
Alessandro Federico, Marcello Dallio, Justyna Godos, Carmela Loguercio, Federico Salomone. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. Translational Research 2016; 167(1): 116 doi: 10.1016/j.trsl.2015.08.002
|
| 22 |
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients 2017; 9(10): 1124 doi: 10.3390/nu9101124
|
| 23 |
Desh Raj, Bhawna Tomar, Amit Lahiri, Shrikant R. Mulay. The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease. Pharmacological Research 2020; 152: 104617 doi: 10.1016/j.phrs.2019.104617
|
| 24 |
Gakuhei Son, Michael Kremer, Ian N. Hines. Contribution of Gut Bacteria to Liver Pathobiology. Gastroenterology Research and Practice 2010; 2010: 1 doi: 10.1155/2010/453563
|
| 25 |
Min Seok Cho, Sang Yeol Kim, Ki Tae Suk, Byung-Yong Kim. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. Journal of Microbiology 2018; 56(12): 855 doi: 10.1007/s12275-018-8346-2
|
| 26 |
Tetyana V. Koval, Ivan V. Chopey, Mykhaylo M. Hechko, Artur V. Kurakh. NON-ALCOHOLIC FATTY LIVER DISEASE IN THE CONTEXT OF ALTERED GUT MICROBIOTA. Wiadomości Lekarskie 2021; 74(4): 1007 doi: 10.36740/WLek202104137
|
| 27 |
Yu-Jie Zhang, Sha Li, Ren-You Gan, Tong Zhou, Dong-Ping Xu, Hua-Bin Li. Impacts of Gut Bacteria on Human Health and Diseases. International Journal of Molecular Sciences 2015; 16(12): 7493 doi: 10.3390/ijms16047493
|
| 28 |
Binrui Chen, Shuwen Zhu, Lijun Du, Huiqin He, John J. Kim, Ning Dai. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model. Scandinavian Journal of Gastroenterology 2017; 52(10): 1065 doi: 10.1080/00365521.2017.1342141
|
| 29 |
Haiming Hu, Aizhen Lin, Mingwang Kong, Xiaowei Yao, Mingzhu Yin, Hui Xia, Jun Ma, Hongtao Liu. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. Journal of Gastroenterology 2020; 55(2): 142 doi: 10.1007/s00535-019-01649-8
|
| 30 |
Domenico Ferro, Francesco Baratta, Daniele Pastori, Nicholas Cocomello, Alessandra Colantoni, Francesco Angelico, Maria Del Ben. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Nutrients 2020; 12(9): 2762 doi: 10.3390/nu12092762
|
| 31 |
Shini Kanezawa, Mitsuhiko Moriyama, Tatsuo Kanda, Akiko Fukushima, Ryota Masuzaki, Reina Sasaki-Tanaka, Akiko Tsunemi, Takahiro Ueno, Noboru Fukuda, Hirofumi Kogure. Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis. International Journal of Molecular Sciences 2023; 24(5): 4603 doi: 10.3390/ijms24054603
|
| 32 |
Tomonori Kamiya, Naoko Ohtani. The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors. International Immunology 2022; 34(9): 467 doi: 10.1093/intimm/dxac020
|
| 33 |
Young Kyung Sung, Geum Youn Gwak, Moon Seok Choi, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee. A Case of Nonalcoholic Steatohepatitis and Small Intestinal Bacterial Overgrowth with Peripheral Edema Caused by Intestinal Bypass Surgery and Relieved by Repair. Gut and Liver 2012; 6(4): 520 doi: 10.5009/gnl.2012.6.4.520
|
| 34 |
Vivian Mota GUIMARÃES, Virgínia Nascimento SANTOS, Patrícia Souza de Almeida BORGES, João Luiz Rodrigues DE FARIAS, Penelope GRILLO, Edison Roberto PARISE. PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS. Arquivos de Gastroenterologia 2020; 57(4): 471 doi: 10.1590/s0004-2803.202000000-82
|
| 35 |
Takaomi Kessoku, Takashi Kobayashi, Kento Imajo, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Yuki Kasai, Anna Ozaki, Michihiro Iwaki, Asako Nogami, Yasushi Honda, Yuji Ogawa, Shingo Kato, Takuma Higurashi, Kunihiro Hosono, Masato Yoneda, Takayuki Okamoto, Haruki Usuda, Koichiro Wada, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima. Endotoxins and Non-Alcoholic Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.770986
|
| 36 |
Yoon Seok Roh, Jong Won Kim, Surim Park, Changho Shon, Sokho Kim, Seong Kug Eo, Jung Kee Kwon, Chae Woong Lim, Bumseok Kim. Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice. The American Journal of Pathology 2018; 188(11): 2574 doi: 10.1016/j.ajpath.2018.07.011
|
| 37 |
Yi Jiang, Salil Chowdhury, Bing-Hong Xu, Mohamad Aghaie Meybodi, Konstantinos Damiris, Samanthika Devalaraju, Nikolaos Pyrsopoulos. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for <i>Clostridioides difficile</i> infection. World Journal of Hepatology 2021; 13(11): 1777-1790 doi: 10.4254/wjh.v13.i11.1777
|
| 38 |
Li-Jian Chen, Jie-Tao He, Ming Pan, Jia-Li Liu, Kai-Kai Zhang, Jia-Hao Li, Li-Bin Wang, Ling-Ling Xu, Yu-Kui Chen, Qin-Yao Zhang, Dong-Ri Li, Jing-Tao Xu, Xiao-Li Xie. Antibiotics Attenuate Methamphetamine-Induced Hepatotoxicity by Regulating Oxidative Stress and TLR4/MyD88/Traf6 Axis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.716703
|
| 39 |
Johanna Iturrino, Madhusudan Grover. Practical Gastroenterology and Hepatology Board Review Toolkit. 2016; : 285 doi: 10.1002/9781119127437.ch47
|
| 40 |
Takaomi Kessoku, Takashi Kobayashi, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Michihiro Iwaki, Anna Ozaki, Yuki Kasai, Asako Nogami, Yasushi Honda, Yuji Ogawa, Shingo Kato, Kento Imajo, Takuma Higurashi, Kunihiro Hosono, Masato Yoneda, Haruki Usuda, Koichiro Wada, Satoru Saito, Atsushi Nakajima. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. International Journal of Molecular Sciences 2021; 22(15): 8161 doi: 10.3390/ijms22158161
|
| 41 |
Elena Ermolenko. Effects of autoprobiotic consortium and fecal transplant on the digestive system and intestinal microbiota in the correction of experimental dysbiosis. Gastroenterology & Hepatology: Open Access 2020; 11(6): 198 doi: 10.15406/ghoa.2020.11.00440
|
| 42 |
Yoon Seok Roh, Ekihiro Seki. Toll‐like receptors in alcoholic liver disease, non‐alcoholic steatohepatitis and carcinogenesis. Journal of Gastroenterology and Hepatology 2013; 28(S1): 38 doi: 10.1111/jgh.12019
|
| 43 |
Mustafa Cengiz, Seren Ozenirler, Sehri Elbeg. Role of serum toll‐like receptors 2 and 4 in non‐alcoholic steatohepatitis and liver fibrosis. Journal of Gastroenterology and Hepatology 2015; 30(7): 1190 doi: 10.1111/jgh.12924
|
| 44 |
Kento Imajo, Masato Yoneda, Yuji Ogawa, Koichiro Wada, Atsushi Nakajima. Microbiota and nonalcoholic steatohepatitis. Seminars in Immunopathology 2014; 36(1): 115 doi: 10.1007/s00281-013-0404-6
|
| 45 |
Dionysius Subali, Mi Hye Kwon, Won Seok Bang, Hee Eun Kang. The pharmacokinetics of mycophenolic acid in rats with orotic acid induced nonalcoholic fatty liver disease. Canadian Journal of Physiology and Pharmacology 2020; 98(3): 169 doi: 10.1139/cjpp-2019-0383
|
| 46 |
Ming-Liang Lu, Hua Huang, Li-Ming Liu, Jiang Chang. The Relationship between Intestinal Motility and Interstitial Cells of Cajal in Nonalcoholic Fatty Liver Mice. Hepatitis Monthly 2013; 13(10) doi: 10.5812/hepatmon.13674
|
| 47 |
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
|
| 48 |
Daisuke Satoh, Takahito Yagi, Takeshi Nagasaka, Susumu Shinoura, Yuzo Umeda, Ryuichi Yoshida, Masashi Utsumi, Takehiro Tanaka, Hiroshi Sadamori, Toshiyoshi Fujiwara. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. World Journal of Hepatology 2013; 5(4): 189-195 doi: 10.4254/wjh.v5.i4.189
|
| 49 |
Xin Dai, Huiqin Hou, Wanru Zhang, Tianyu Liu, Yun Li, Sinan Wang, Bangmao Wang, Hailong Cao. Microbial Metabolites: Critical Regulators in NAFLD. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.567654
|
| 50 |
Paraskevas Gkolfakis, George Dimitriadis, Konstantinos Triantafyllou. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2015; 14(6): 572 doi: 10.1016/S1499-3872(15)60026-1
|
| 51 |
Toral Manvar, Vijay Lakhujani. Encyclopedia of Bioinformatics and Computational Biology. 2019; : 200 doi: 10.1016/B978-0-12-809633-8.20503-7
|
| 52 |
Guoliang Dai, Bingting Sun, Lei Wu, Xiaojun Gao, Shanshan Song, Hong Sun, Wenzheng Ju. Comparative pharmacokinetics of three alkaloids in normal and acute hepatitis rats after oral administration of Yanhuanglian total alkaloids extract. Biomedical Chromatography 2018; 32(11) doi: 10.1002/bmc.4329
|
| 53 |
Richard G McGee, Anouk Bakens, Kerrie Wiley, Stephen M Riordan, Angela C Webster, Richard G McGee. Cochrane Database of Systematic Reviews. 2011; doi: 10.1002/14651858.CD008716.pub2
|
| 54 |
Deepa Rana, Ajay Duseja, Radha K. Dhiman, Yogesh Chawla, Sunil K. Arora. Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxin. Hepatology International 2013; 7(2): 562 doi: 10.1007/s12072-012-9371-6
|
| 55 |
Fouad M. F. Elshaghabee, Namita Rokana, Harsh Panwar, Knut J. Heller, Jürgen Schrezenmeir. Pharmaceuticals from Microbes. Environmental Chemistry for a Sustainable World 2019; 28: 207 doi: 10.1007/978-3-030-04675-0_8
|